If you or someone you love has been harmed by Crestor (rosuvastatin calcium), you may be entitled to compensation. Since 1988, personal injury victims have turned to Martinez, Manglardi, Diez-Arguelles & Tejedor, P.A. for help in their personal injury claims. Our team of professionals includes nurses, doctors, engineers and other experts who are backed by leading technology that enables us to keep in touch with the legal community, legislative developments and our clients. Our attorneys have worked hard to ensure that negligent manufacturers and suppliers are held accountable for the injuries and fatalities caused by their unsafe products. We have helped Floridians receive millions of dollars in favorable verdicts and settlements. In addition to our dangerous drug cases, we provide counsel on personal injury, wrongful death, motor vehicle crashes, product liability, medical malpractice, nursing home abuse, insurance contract disputes and theme park negligence claims. If you or someone you know used Crestor and has suffered adverse effects from its use, we encourage you to contact our office today to discuss your situation.

Crestor (rosuvastatin calcium) is part of the statin family of powerful medicines used to treat high cholesterol. Crestor was approved by the Food & Drug Administration (FDA) in August of 2003 and since then the drug has been surrounded by controversy. Shortly after its approval, the FDA issued a Public Health Advisory regarding the drug. Patients with under active thyroids or kidney problems are at increased risk for rhabdomolysis when they take Crestor. Rhabdomolysis is a severe muscle-wasting condition that often results in kidney damage and can be fatal. Another statin drug, cerivastatin (Baycol), has already been removed from the market because of reports of rhabdomyolysis and fatalities, and Crestor has the same potential for kidney toxicity. Crestor is the only remaining medication in the statin family to cause elevated urine protein, a potential warning sign of serious kidney problems.

Astra-Zeneca Pharmaceuticals, the U.K.’s second-largest pharmaceutical producer, manufactures Crestor. In June of 2004, the London-based company issued a revised package insert for Crestor in Europe. Physicians have been advised to start patients on the lowest possible dose of the drug and prescriptions for the highest dose have been moved to the “specialist supervision” category. The letters also advise that prescriptions are prohibited in cases where patients are at high risk for rhabdomyolysis. Astra-Zeneca has discontinued production of its 80 milligram strength dose and also placed special restrictions on the distribution its 40 milligram dosage.

If you or someone you love has been injured or has died because of the adverse effects of Crestor, you may be entitled to receive compensation. Martinez, Manglardi, Diez-Arguelles & Tejedor, P.A. verdicts and settlements are among the highest in Florida. Remember, we represent our clients’ interests – not those of pharmaceutical giants or insurance companies. Let us help you make informed decisions about your claim. We’ll provide a free consultation in your home, at the hospital or in our offices. Contact us today in Orlando at (407) 381-4123, or in Kissimmee, (407) 846-2240 or via our online contact form.

Recent Crestor News

FDA to Create New Drug Safety Board (February 15, 2005)
The U.S. Food and Drug Administration said on Tuesday it was creating a new drug safety board to improve the monitoring of medicines already in the marketplace, a response to charges the agency has failed to protect the public from dangerous side effects

FDA Official Warns Congress About 5 Drugs, Including Crestor
Dr. David Graham, a Food and Drug Administration official, told the Senate Finance Committee last Friday that the FDA would be unable to protect the country from another Vioxx case.